床旁与电子检测颅内压危象的一致性:来自重型创伤性脑损伤脑组织氧监测与管理II试验的启示
该研究为BOOST II随机试验的事后分析,纳入10个美国ICU中70例有完整数据的重型TBI患者,比较床旁ICP(B-ICP)识别与背景采集的电子ICP(E-ICP)数据对极简ICP危象(持续≤60分钟、仅需一级治疗)的识别一致性。床旁医师识别并治疗了509次极简B-ICP危象(定义为B-ICP≥20 mm Hg持续5分钟),相应时段E-ICP仅确认47%。在241次一致危象中,38%的整个危象期间平均E-ICP<20 mm Hg;在286次不一致危象中,76%平均E-ICP<20 mm Hg,31%平均和最大E-ICP均<20 mm Hg。混杂测试未提供解释。作者认为当前床旁识别方法可能无法可靠区分真正的持续ICP升高,建议开发开源、实时、时间同步的电子B-ICP危象定义方法。
要点
- 床旁医师识别并治疗的509次极简B-ICP危象中,同步E-ICP仅确认47%。
- 在241次一致危象中,38%的整个危象期间平均E-ICP<20 mm Hg。
- 在286次不一致危象中,76%平均E-ICP<20 mm Hg,31%平均和最大E-ICP均<20 mm Hg。
- 极简B-ICP危象占BOOST II全部孤立ICP危象的83%,定义为B-ICP≥20 mm Hg持续5分钟且仅需一级治疗。
- 作者建议开发开源、实时、时间同步的电子B-ICP危象定义方法以指导未来治疗和研究。
适用人群与场景
- BOOST II随机试验中110例重型TBI患者里70例有完整数据集者,来自10个美国ICU。
诊断标准与关键阈值
- 极简B-ICP危象定义为床旁ICP≥20 mm Hg持续5分钟,持续≤60分钟且仅需一级治疗。
- 一致危象定义为B-ICP 5和E-ICP 5均≥20 mm Hg;不一致危象定义为B-ICP 5≥20 mm Hg但E-ICP 5<20 mm Hg。
研究设计与关键结果
- 研究类型:BOOST II随机试验的事后比较分析,比较背景采集的连续E-ICP数据与常规B-ICP信息。
- 样本量:70例重型TBI患者,来自10个美国ICU。
- 极简B-ICP危象占BOOST II全部孤立ICP危象的83%。
- 床旁医师识别并治疗509次极简B-ICP危象,相应时段E-ICP仅确认47%。
- 241次一致危象中,38%的整个危象期间平均E-ICP<20 mm Hg。
- 286次不一致危象中,76%平均E-ICP<20 mm Hg,31%平均和最大E-ICP均<20 mm Hg。
- 混杂测试(如短暂、首次或易控制的B-ICP危象)未提供解释。
证据类型、等级与局限
- 证据类型:随机试验的事后比较分析。
- 局限:缺乏严格的B-ICP危象结束定义;无法完全控制时间同步混杂;数据不足以评估床旁与电子数据点之间的时间不同步。
对床旁实践的改变
- 作者认为当前床旁识别B-ICP危象的方法可能无法可靠区分最常见的B-ICP危象类型中的真正持续ICP升高。
- 作者建议开发开源、实时、时间同步的电子B-ICP危象定义方法以指导未来治疗和研究。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: Traumatic brain injury (TBI) research and intracranial pressure (ICP) management depends on bedside ICP (B-ICP) crisis identification. We analyzed background-collected electronic ICP (E-ICP) data to study the concordance of this identification.
DESIGN: Post hoc comparison of background-collected continuous E-ICP data to routine B-ICP information during severe TBI management in the Brain Tissue Oxygen Monitoring and Management in Severe TBI (BOOST II) randomized trial.
SETTING: Ten U.S. ICUs.
PATIENTS: Seventy of 110 randomized BOOST II severe TBI patients with complete datasets for this study.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: We studied "minimalist" B-ICP episodes lasting less than or equal to 60 minutes and requiring only tier 1 treatments (83% of total BOOST II I isolated ICP episodes). Bedside clinicians (BCs) identified and treated 509 minimalist B-ICP episodes, defined by 5 minutes of B-ICP greater than or equal to 20 mm Hg (B-ICP 5 ). Corresponding E-ICP during this defining period (E-ICP 5 ) confirmed only 47% of these. The 241 "concordant" B-ICP episodes (both B-ICP 5 and E-ICP 5 ≥ 20 mm Hg) had average E-ICP values for the entire B-ICP episodes (E-ICP AVG ) less than 20 mm Hg in 38%. The 286 "discordant" B-ICP episodes (B-ICP 5 ≥ 20 mm Hg but E-ICP 5 < 20 mm Hg) had E-ICP AVG values less than 20 mm Hg in 76% and both E-ICP AVG and maximal E-ICP's (E-ICP MAX ) values less than 20 mm Hg in 31%. Testing for confounding (e.g., brief, first, or easily controlled B-ICP episodes) did not provide explanations. Insufficient data were available to evaluate temporal asynchrony between BC and electronic datapoints. Study limitations were lacking a rigid end-of-B-ICP episode definition and inability to fully control for temporal synchrony confounding.
CONCLUSIONS: Our findings suggest that current methods of clinical identification of B-ICP episodes may not reliably distinguish true episodes of sustained ICP for the most common B-ICP episode type. We suggest developing open-source, real-time, temporally synchronized electronic B-ICP episode definition methods to direct future treatment and research.
参考来源
- Chesnut RM, Temkin N, Barber J, et al. Concordance Between Bedside and Electronic Detection of Intracranial Pressure Crises: Insights From the Brain Tissue Oxygen Monitoring and Management in Severe Traumatic Brain Injury II Trial. Crit Care Med. 2026. PMID: 42302399. doi:10.1097/CCM.0000000000007223
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。